#Sustainability #USA #Piscataway #GenScript Biotech #Carbon Emission

GenScript Biotech Corp's Commitment to Sustainability

In a significant step towards combating climate change, GenScript Biotech Corp, a prominent player in life sciences research and development, has proclaimed an ambitious carbon emission reduction initiative, recently certified by the Science Based Targets initiative (SBTi). This milestone aligns the company's objectives closely with the Paris Agreement's goal of limiting global warming to 1.5°C, underscoring GenScript's dedication to fostering a low-carbon future.

Setting the Scene: A Bold Commitment

On February 18, 2025, GenScript Biotech announced its commitment to achieving a 54.6% reduction in greenhouse gas emissions by the year 2033. This target encompasses both direct and indirect emissions, representing a comprehensive approach to environmental responsibility. Furthermore, the company is striving to cut emissions from fuel use, energy-related activities, and waste generated throughout its operations by 32.5% over the same timeframe.

To ensure efficacy in reaching these goals, GenScript plans to work closely with its suppliers, who account for 83% of its Scope 3 emissions, guiding them to adopt their own science-based targets by 2029. This collaborative effort is emblematic of GenScript's approach, recognizing that substantial emission reductions require a collective commitment across the supply chain.

Long-Term Vision: A Path Towards Net-Zero

GenScript's plans do not stop at near-term targets; the company also aspires to achieve net-zero emissions across its entire value chain by 2050. Sherry Shao, GenScript's rotating CEO, emphasized the critical nature of addressing climate change, stating, "GenScript has always adhered to its mission of 'using biotechnology to make humans and nature healthier.' With the recent successful verification of our carbon reduction targets by SBTi, we have established more scientific and actionable goals."

Implementing Effective Measures

To accomplish its ambitious carbon reduction targets, GenScript is deploying a series of proactive measures. In energy conservation, the company has enhanced its reliance on renewable energy through the installation of rooftop photovoltaic systems. These efforts are complemented by an overhaul of energy management, including the introduction of smart power management systems designed to optimize energy efficiency and minimize waste.

The introduction of the GenScript Environmental Sustainability Policy marks a pivotal moment in the company’s journey towards sustainability. This policy integrates energy-saving and emission-reduction strategies into all areas of its operation, including production, logistics, and overall management, thus laying a robust foundation for its green transformation.

Climate Governance: A Collective Responsibility

With climate governance entering a transformative period, GenScript stands out as a model for effective low-carbon transformation and adherence to Environmental, Social, and Governance (ESG) principles. The recent endorsement from SBTi serves not only as recognition of the company’s endeavors but also as a springboard for future sustainable development efforts.

Further aiming at expanding its green pathways, GenScript is committed to contributing to a cleaner, more stable, and prosperous world. It embodies the belief that responsible business practices can go hand in hand with economic progress, improving both ecological and social outcomes globally.

About GenScript Biotech Corporation

Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in healthcare and consumer goods. It supports researchers and companies in developing groundbreaking treatments and products. With a workforce of over 5,000 and a customer base exceeding 200,000 across over 100 countries, GenScript continues to lead as a trusted partner in biotechnology, driving efforts to make both people and nature healthier through innovative solutions. Learn more at GenScript's official website.